Deerfield Beach, FL -- (SBWIRE) -- 01/11/2017 -- Pruritus is a chronic itching condition caused due to dermatological disease including atopic dermatitis, contact dermatitis, mycoses, chickenpox etc. Growing prevalence of diseases like atopic dermatitis, allergic contact dermatitis and urticaria around the world is expected to drive pruritus therapeutics market.

Increasing global prevalence of atopic dermatitis, allergic contact dermatitis and urticaria is expected to drive the pruritus therapeutics market over the forecast period. Development of new and a strong pipeline for pruritus therapeutics attributes to the rising demand of pruritus therapeutics over the forecast period. However, lack of awareness of the root cause of pruritus and a universally accepted therapy for pruritus is expected to hamper growth of pruritus therapeutics industry.

Get Sample Research Report at: http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=61517

The report provides a comprehensive view on the pruritus therapeutics; we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter's Five Forces model for the pruritus therapeutics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness. The market size and forecasts in terms of revenue (USD million) for the period 2015 to 2020, considering 2014 as the base year, have been provided for this segment of the report.

The report segments the pruritus therapeutics market on the basis of type, disease type and geography. Corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressant, calcineurin inhibitors and others are major product segment of pruritus therapeutics market analyzed in this study. Corticosteroid was the leading product segment of pruritus therapeutics market in 2014 in terms of revenue. On the basis of type of disease, pruritus therapeutics is segmented into atopic dermatitis, allergic contact dermatitis, urticaria and others. The global demand for pruritus therapeutics increases due to high prevalence of dermatological disorders.

Browse the full report at: http://www.syndicatemarketresearch.com/market-analysis/pruritus-therapeutics-market-global-industry-perspective-comprehensive-analysis.html

Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, further bifurcation of region on the country level, which include U.S., Germany, UK, France, China, Japan and India. Invention of new products and the existence of favorable government initiatives are expected to show lucrative growth in North America over the forecast period. Due to which North America dominated the overall industry in terms of revenue in 2014.

The key players of the pruritus therapeutics market include Pfizer, Tai Guk Pharmaceutical Company, Cara Therapeutics, Sanofi, Actavis, Trevi Therapeutics, Ocera Therapeutics Inc. and NeRRe Therapeutics.

The report segments the global pruritus therapeutics market into:

Global Pruritus Therapeutics Market: Product Segment Analysis

Corticosteroids
Antihistamines
Local Anesthetics
Counterirritants
Immunosuppressant
Calcineurin Inhibitors
Others

Global Pruritus Therapeutics Market: Disease Type Segment Analysis

Atopic Dermatitis
Allergic Contact Dermatitis
Urticaria
Others

Global Pruritus Therapeutics Market: Regional Segment Analysis

North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East & Africa

Contact US:
Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email: sales@syndicatemarketresearch.com
Website: http://www.syndicatemarketresearch.com